HemaSphere (Aug 2023)
PB2272: PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL
- Lihua Qiu,
- Tingyu Wang,
- Xiuhua Sun,
- Hang Su,
- Junning Cao,
- Zhi-Ming LI,
- Yuqin Song,
- LI Zhang,
- Dengju LI,
- Huijing Wu,
- Wei Zhang,
- Junmin LI,
- Keshu Zhou,
- Hui Zhou,
- Yu Yang,
- Zhifeng LI,
- Hong Cen,
- Zhen Cai,
- Zhihui Zhang,
- Weijun Fu,
- Jie Jin,
- Fei LI,
- Weixin Wu,
- Xuekui Gu,
- Weiliang Zhu,
- Lihong Liu,
- Zengjun LI,
- Shuhua Yi,
- Lugui Qiu
Affiliations
- Lihua Qiu
- 1 Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Department of Lymphoma, Tianjin, China
- Tingyu Wang
- 2 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin, China
- Xiuhua Sun
- 3 The Second Hospital of Dalian Medical University, Department of Medical Oncology, Dalian, China
- Hang Su
- 4 The Fifth Medical Center of PLA General Hospital, Department of Lymphoma, Senior Department of Hematology, Beijing, China
- Junning Cao
- 5 Fudan University Shanghai Cancer Center, Department of Medical Oncology, Shanghai, China
- Zhi-Ming LI
- 6 Sun Yat-sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
- Yuqin Song
- 7 Peking University School of Oncology, Beijing Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Beijing, China
- LI Zhang
- 8 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
- Dengju LI
- 9 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, Wuhan, China
- Huijing Wu
- 10 Hubei Cancer Hospital, Department of Medical Oncology, Wuhan, China
- Wei Zhang
- 11 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
- Junmin LI
- 12 Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai, China
- Keshu Zhou
- 13 The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Department of Hematology, Zhengzhou, China
- Hui Zhou
- 14 Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Department of Lymphoma & Hematology, Changsha, China
- Yu Yang
- 15 Fujian Provincial Cancer Hospital, The Affiliated Tumor Hospital of Fujian Medical University, Department of Lymphoma and Head and Neck Cancer, Fuzhou, China
- Zhifeng LI
- 16 The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Department of Hematology, Xiamen, China
- Hong Cen
- 17 Guangxi Medical University Affiliated Cancer Hospital, Department of Haematology/Oncology and Paediatric Oncology, Nanning, China
- Zhen Cai
- 18 he First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China
- Zhihui Zhang
- 19 Sichuan Cancer Hospital and Institute, Department of Medical Oncology, Chengdu, China
- Weijun Fu
- 20 Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Department of Hematology, Shanghai, China
- Jie Jin
- 18 he First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China
- Fei LI
- 21 The First Affiliated Hospital of Nanchang University, Department of Hematology, Nanchang, China
- Weixin Wu
- 22 Zhongshan Hospital, Xiamen University, Department of Internal Medicine and Oncology, Xiamen, China
- Xuekui Gu
- 23 The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Department of Hematology, Guangzhou, China
- Weiliang Zhu
- 24 Zhujiang Hospital of Southern Medical University, Department of Oncology, Guangzhou, China
- Lihong Liu
- 25 The Fourth Hospital of Hebei Medical University, Department of Hematology, Shijiazhuang, China
- Zengjun LI
- 2 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin, China
- Shuhua Yi
- 2 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin, China
- Lugui Qiu
- 2 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin, China
- DOI
- https://doi.org/10.1097/01.HS9.0000975820.37624.bc
- Journal volume & issue
-
Vol. 7
p. e37624bc
Abstract
No abstracts available.
